跳至主要内容
临床试验/NCT05888519
NCT05888519已完成不适用

Evaluation of Safety and Tolerability of Investigational Ocular Lubricants

Alcon Research6 个研究点 分布在 1 个国家目标入组 47 人开始时间: 2023年7月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
47
试验地点
6
主要终点
Best corrected visual acuity (BCVA) with manifest refraction, at distance

研究概览

简要总结

The purpose of this study is to evaluate investigational ocular lubricants for their safety and tolerability on subjects with mild to moderate dry eye disease.

详细描述

Subjects will be expected to attend a screening visit followed by 6 additional study visits. The expected duration of subject participation is approximately 3 weeks. This study will be conducted in Australia.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Sign an Informed Consent;
  • Have dry eye symptoms;
  • Other protocol-specified inclusion criteria may apply.

排除标准

  • Ocular abnormalities;
  • Active ocular infection or inflammation not associated with dry eye;
  • History of ocular or intraocular surgery;
  • Other protocol-defined exclusion criteria may apply.

结局指标

主要结局

Best corrected visual acuity (BCVA) with manifest refraction, at distance

时间窗: Day 1, each wear period. A wear period is 1 day.

BCVA will be collected for each eye individually and recorded in logarithm Minimum Angle of Resolution (logMAR)

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验

Evaluation of Safety and Tolerability of... | 临床试验